| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.46 | 6e-12 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-11 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.39 | 5e-10 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.41 | 1e-08 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |